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 Cancer is estimated to be the second leading cause of death 
globally in 2018. The background of the study was the 
prevalence of cancer in Indonesia in 2018 reaching 775.120 
people. Treatments such as surgery, chemotherapy, 
radiotherapy, immunotherapy, and hormone therapy have 
negative side effects. Herbal medicine is an alternative 
treatment with lower side effects that can reduce the side effects 
of existing treatments. The aim of this study was to identify the 
results of GC-MS active compounds from ethanol extract of 
zodia leaves which have the potential as anticancer. The 
method of this research was observational research through 
scientific literature. GC-MS results showed 22 active 
compounds contained in ethanol extract of zodia leaves. Based 
on the literature searching, there are 17 active compounds that 
have potential to be anticancer. Menthofuran; evodone; 
Bicyclopentene; Delta-Selinene; 3,5,7-Octatrien-2-Ol, 2,6-
Dimethyl; Aromadendrene oxide 2; Alpha-bisabolol; 2,4-
Dimethyl-2,4-Heptadienal; Phytol; Squalene; Beta-Tocopherol; 
D-alpha-Tocopherol; Stigmasta-5,23-dien-3.beta.-ol; (23S)-
ethylcholest-5-en-3.beta.ol; 24,25-Dihydrolanosterol; 
Lanosterol; and Obtusifoliol. The compounds are targeted in 
breast, lung, and ovarian cancer.  
Herbal medicine 
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Introduction 
Cancer is a disease that characterized 
by excessive cell growth can attack 
adjacent body parts or spread to other 
organs. Based on the WHO (World Health 
Organization) cancer is estimated to be the 
second leading cause globally in 2018 
(Organization, 2019). The prevalence of 
cancer in Indonesia in 2018 reached 
775,120 people with mortality reaching 
207,210 of 348,809 cases. 
Some approaches used to treat cancer 
ar surgery, chemotherapy, radiotherapy, 
immunoterapy, targeted therapy, and 
hormone therapy (Health, 2019). Therapy 
can be given separately or in combination 
as adjuvant or neoadjuvant depending on 
the stage of the cancer (Nurhayati & 
Lusiyanti, 2006; Sari, Wahid, & Suchitra, 
2019). Surgery and radiotherapy treatment 
are effective for early cancer, but not for 
metastatic cancer. Chemotherapy, targeted 
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therapy, and hormone therapy are more 
appropriate for metastatic cancer (Chabner 
& Roberts, 2005). But these treatments 
cause side effects, chemotherapy can affect 
normal cells and some drugs cannot be 
combined because it can strengthen the 
work of other drugs that can increase their 
side effects to cause death (Lander et al., 
2001; Sari et al., 2019). Radiotherapy can 
affect normal cells causing xerostomia, 
central nerve complications, and RIHD 
(Radiation Induced Heart Desease) 
(Fitriatuzzakiyyah, Sinuraya, & Puspitasari, 
2017). To reduce these side effects it is 
necessary to find anticancer agents from 
natural products to prevent and cure cancer. 
Herbal medicine is an alternative 
therapy because it is considered to have 
lower side effects and can even reduce the 
side effects of chemotherapy and 
radiotherapy (Radji, Aldiarti, Harahap, & 
Irawan, 2010). Based on the Minister of 
Health Decree in 2007, Indonesia has 
30,000 plant species which 300 species 
have been used as traditional medicinal 
materials from 9,600 species as medicinal 
plants. Some plants that are used as 
anticancer include crown god (Phaleria 
macrocarpa), turmeric (Curcuma longa), 
white turmeric (Curcuma zedoaria), 
kopasanda (Chromolaena odorata L.) and 
red fruit (Pandanus conoideus) (Fitrah, 
Winarno, & Simanjuntak, 2017; Lisdawati, 
2009; Mutiah, 2015; Radji et al., 2010). 
Research related to curcumin activity as an 
anticancer has been widely carried out both 
in vivo, in vitro, until clinical studies. 
Based on research that has been done, the 
administration of curcumin monotherapy 
can reduce the volume of bladder cancer 
using human bladder cancer on orthotopic 
mouse models. In silico and in vivo 
research shows that curcumin plays a role 
in inhibiting cell apoptosis and regulating 
transcription factors (Mutiah, 2015). 
Indonesian endemic plants that have 
the potential to be anticancer namely zodia 
(Evodia suaveolens) which is commonly 
found as ornamental plants in Java 
(Kusnoto, 2007). Zodia is often used as an 
anti-mosquito by rubbing it directly on the 
body, formed as soap, and spray (Muhamat, 
Wahyuni, Rusmiati, & Jumar, 2016; 
Simaremare, Sinaga, & Agustini, 2017). 
Studies that have been done stated that the 
content of evodiamine in Zodia (Evodia 
sauveolens) has been shown to have 
anticancer activities by inhibiting 
proliferation, invasion, and metastasis, and 
inducing apoptosis in various types of 
tumor cells (Jiang & Hu, 2009).  
Testing of plant compounds as 
potential drugs can be done in vivo and in 
vitro, but this method requires a lot of cost 
and time, so it is necessary to first examine 
the interaction of compounds with receptors 
while eliminating compounds that have low 
activity through the in silico test (Ekins, 
Mestres, & Testa, 2007; Ruswanto, 2015). 
Untuk mengurangi kekurangan tersebut 
dapat diatasi dengan menggunakan uji 
secara komputasi atau in silico. The 
computational testing or in silico can 
reduce these deficiencies and could be done 
by many methods, one of which is 
molecular docking. Molecular docking is a 
computational procedure that describes 
interactions between drug molecules as 
ligands and protein receptors (Suhud, 
2015). Before conducting the in silico test, 
it is necessary to identify the active 
compound contained in a sample to be 
tested.  
There are many methods that can be 
used to identify active compounds 
contained in a sample. One of method used 
is Gas Chromatography - Mass Spectrum 
(GC-MS), a chromatographic technique to 
detect volatile compounds and identify 
molecular weights and molecular formulas 
(Darmapatni, Basori, & Suaniti, 2016). This 
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study aims to identify and determine the 
active compound from ethanol extract of 
zodia leaves from GC-MS analysis which 
has the potential as an anticancer. 
 
Material and Methode 
This research was conducted in April 
2019 at the Physiology Laboratory of the 
Biology Department of the Faculty of 
Mathematics and Natural Sciences, 
University State of Surabaya. The tools 
used in this study include blenders, rotary 
evaporators, and GC-MS tools. The 
ingredients used are zodia leaves, 96% 
ethanol, and filter paper. The steps taken 
are: 
1. Sampling 
The zodia (Evodia suaveolens) 
leaves collection was obtained from several 
locations of gardens and yards in the 
Surabaya that cultivated the plants to obtain 
sufficient quantities for extraction.  
2. Extraction Zodia Leaves (Evodia 
suaveolens) 
Zodia leaves are washed and then 
dried for three days and avoided from the 
sun. The leaves are dried using an oven for 
two to three days at 60
o
C, then mashed with 
a blender until it becomes powder and 
sifted using a 40 mesh sieve. The zodia 
leaves powder macerated using 96% polar 
solvent for 3 days with the concentration of 
the solvent compared to the first day was 1 : 
3 (weight : volume) while the concentration 
on the second and third days was 1: 1 
(weight : volume). The results of 
maceration were evaporated using a rotary 
evaporator to form a paste. The extraction 
results are 100% extract of zodia leaf. 
3. Identification Active Compound 
The identification of active 
compounds contained in zodia leaf extract 
will be carried out using GC-MS analysis. 
Analysis using the AGILENT 6980N 
Network GC System with an autosampler. 
The sample is heated at a temperature of 
50-280 °C with an increase in temperature 
of 100 °C / minute and leave it for 10 
minutes. Helium gas is used as a career 
with a flow of 1.3 ml / minute. Heat the 
injector at 280 °C, the size of the injection 
of 1µl neat, with a split ratio of 1:10. The 
interface and source of the MS ion are 
maintained at 230 °C and 150 °C carefully. 
The mass spectrum is obtained at 70 eV and 
in the reading range 200 - 700 amu. The 
data obtained was analyzed in the GC-MS 
solution software. This stage was carried 
out in the Testing Service Unit (ULP), 
Faculty of Pharmacy, Airlangga University 
Surabaya. 
 
Results and Discussions 
This research was a descriptive 
experimental study by identifying 
potentially anticancer compounds from the 
results of GC-MS test ethanol extract of 
zodia leaves (figure 1). 
From the GC-MS test results, 22 
names of compounds were identified 
through the pubchem.ncbi.nlm.nih.gov 
database (Table 1). Of the 22 compounds 
there are 17 compounds that have the 
potential to be anticancer. Based on web 
server  swisstargetprediction.ch  analysis, 
menthofuran; evodone; Bicyclopentene; 
Delta-Selinene; 3,5,7-Octatrien-2-Ol, 2,6-
Dimethyl-; aromadendrene oxide 2; Alpha-
bisabolol; 2,4-Dimethyl-2,4-Heptadienal; 
Phytol; Squalene; (23S)-ethylcholest-5-en-
3.beta.ol; 24,25-Dihydrolanosterol; 
Lanosterol; dan Obtusifoliol compound are 
potential as breast anticancer targeted at 
CYP450 gene. In breast cancer, one of the 
genes that is targeted by these compounds 
is CYP19A1 which is a gene that encodes 
the aromatase enzyme (Hamid, Sugiyanto, 
Meiyanto, & Widyarini, 2009). This 
enzyme role is to catalyze C19 androgens 
become C18 estrogen. Estrogen and 
estrogen receptor complexes will stimulate 
the growth of breast epithelial tissue and 
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have a local effect. Polymorphism in one of 
the enzyme coding genes or estrogen 
receptors will cause changes in milieu of 
the breast and potentially cause malignancy 
(Crandall et al., 2009).  
Evodone has the potential as an 
anticancer ovary through its interaction 
with the influential 3HHM protein on the 
PI3KCA pathway. This pathway is one of 
the signal transduction pathways that plays 
a role in cell proliferation and 
differentiation. In cancer cells, this pathway 
experiences hyperactivation resulting in 
excessive activation of protein kinase B 
(PKB) (Brown & Toker, 2015). Excessive 
activity of PKB causes inhibition of pro-
apoptotic protein activation, activation of 
anti-apoptotic proteins, and increased 
metastasis (McDonald, 2008). 
 
 
Figure 1. GC-MS Test Results Ethanol Extract of Zodia Leaves 
 
Table 1. Compound Identification Results 
Peak Retention time 
(minute) 
Komposi-tion (%) The name of compound 
1 7,6 1,24 Menthofuran 
2 10,59 14,74 Evodone  
3 11,48 0,81 Caryophyllene 
4 11,61 1,42 1,1'-Bicyclopentene 
5 11,98 1,32 Alpha-Gurjenene 
6 12,46 2,14 Delta-Selinene 
7 13,46 1,17 3,5,7-Octatrien-2-Ol, 2,6-Dimethyl- 
8 13,69 1,33 Aromadendrene oxide 2 
9 13,94 5,04 Alpha-bisabolol 
10 14,02 4,74 Gamma-Selinene 
11 15,23 8,04 2,4-Dimethyl-2,4-Heptadienal 
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Peak Retention time 
(minute) 
Komposi-tion (%) The name of compound 
12 18,04 0,77 - 
13 18,91 0,51 Bicyclo[2.2.1]heptane, 2-ethenyl-2, 
4-bishomobrendan-7-one 
14 19,18 5,76 Phytol 
15 24,49 1,31 Squalene 
16 25,95 2,76 Beta-Tocopherol 
17 26,5 7,79 D-alpha-Tocopherol 
18 27,33 3,94 Stigmasta-5,23-dien-3.beta.-ol 
19 27,67 5,8 (23S)-ethylcholest-5-en-3.beta.ol 
20 27,85 12,82 24,25-Dihydrolanosterol 
21 28,28 16,55 Lanosterol 
22 29,03 16,55 Obtusifoliol 
 
Compounds that have the potential 
to be anticancer lungs, namely evodone; 
3,5,7-Octatrien-2-Ol, 2,6-Dimethyl; 2,4-
Dimethyl-2,4-Heptadienal; Phytol; and 
Squalene with protein targets namely 
EGFR, CCNE1, and CYP450. EGFR 
(Epidermal Growth Factor Receptor) is a 
170-kDa glycoprotein protein tyrosine 
kinase which is present in cell membranes. 
In normal cells EGFR expression includes 
epidermal, mesenchymal, and neurogenic 
cells. EGFR expression when binding to 
EGF activates cell proliferation and 
differentiation. DNA mutations in EGFR as 
detected by polymerase chain reaction 
(PCR) can occur in the appropriate area 
with parts of extracellular or intracellular 
proteins. In non-small cell lung cancer, 
overexpression of EGFR or mutations in 
intracellular EGFR (Bethune, Bethune, 
Ridgway, & Xu, 2010; Inamura, Ninomiya, 
Ishikawa, & Matsubara, 2010). 
Based on searching through a Swiss 
Target webserver, it can be seen that the 
compounds of Beta-Tocopherol and 
Stigmasta-5,23-dien-3.beta.-ol have 
potential to be lung anticancer and 
colorectal by targeting epidermal growth 
factor erbB1 (EGFR) which is on protein 
kinase. The EGFR gene starts when the 
ligand is bound to the outermost part of the 
EGFR receptor protein so that another 
homodimer or heterodimer structure will be 
formed. The results of the formation of this 
structure will activate the receptor kinase 
and autophosphorylate specific tyrosine 
residues that have the ends of the -COOH 
group. The autophosphorylation process 
will activate the signal transduction 
pathways that are regulated by EGFR such 
as the AKT and ERK pathways that control 
several cellular processes (Ladanyi & Pao, 
2008). 
 
Conclusion 
Based on research that has been 
done, it can be seen that the active 
compounds contained in the ethanol extract 
of zodia leaves which have the potential as 
anticancer, there are Menthofuran; evodone; 
Bicyclopentene; Delta-Selinene; 3,5,7-
Octatrien-2-Ol, 2,6-Dimethyl; Aromadendrene 
oxide 2; Alpha-bisabolol; 2,4-Dimethyl-2,4-
Heptadienal; Phytol; Squalene; Beta-
Tocopherol; D-alpha-Tocopherol; Stigmasta-
5,23-dien-3.beta.-ol; (23S)-ethylcholest-5-en-
3.beta.ol; 24,25-Dihydrolanosterol; Lanosterol; 
and Obtusifoliol. The compounds are targeted 
in breast, lung, and ovarian cancer. 
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